- Home
- PLRX vs CAC Comparison
PLRX vs CAC Comparison
Compare PLRX & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- CAC
- Stock Information
- Founded
- PLRX 2015
- CAC 1875
- Country
- PLRX United States
- CAC United States
- Employees
- PLRX N/A
- CAC N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- CAC Major Banks
- Sector
- PLRX Health Care
- CAC Finance
- Exchange
- PLRX Nasdaq
- CAC Nasdaq
- Market Cap
- PLRX 89.0M
- CAC 688.3M
- IPO Year
- PLRX 2020
- CAC 1997
- Fundamental
- Price
- PLRX $1.46
- CAC $39.82
- Analyst Decision
- PLRX Hold
- CAC Buy
- Analyst Count
- PLRX 10
- CAC 3
- Target Price
- PLRX $3.93
- CAC $48.00
- AVG Volume (30 Days)
- PLRX 692.5K
- CAC 56.5K
- Earning Date
- PLRX 11-06-2025
- CAC 10-28-2025
- Dividend Yield
- PLRX N/A
- CAC 4.22%
- EPS Growth
- PLRX N/A
- CAC 4.80
- EPS
- PLRX N/A
- CAC 3.11
- Revenue
- PLRX N/A
- CAC $197,501,000.00
- Revenue This Year
- PLRX N/A
- CAC $42.11
- Revenue Next Year
- PLRX N/A
- CAC $5.51
- P/E Ratio
- PLRX N/A
- CAC $12.78
- Revenue Growth
- PLRX N/A
- CAC 21.74
- 52 Week Low
- PLRX $1.10
- CAC $34.53
- 52 Week High
- PLRX $16.10
- CAC $50.07
- Technical
- Relative Strength Index (RSI)
- PLRX 40.86
- CAC 47.61
- Support Level
- PLRX $1.66
- CAC $39.82
- Resistance Level
- PLRX $1.85
- CAC $40.75
- Average True Range (ATR)
- PLRX 0.12
- CAC 0.84
- MACD
- PLRX -0.03
- CAC -0.08
- Stochastic Oscillator
- PLRX 2.27
- CAC 16.49
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.